Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)

NCT05387278 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor request

Conditions

COVID-19 Acute Respiratory Distress Syndrome
Respiratory Distress Syndrome

Interventions

DRUG: EV-Pure™ and WJ-Pure™
DRUG: Placebo

Sponsor

Vitti Labs, LLC